| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |